生殖系ERG单倍剂量不足定义一种新的血细胞减少和血液系统恶性肿瘤易感综合征
该研究报告发现ETS相关基因(ERG)是新的常染色体显性遗传骨髓衰竭(BMF)和血液系统恶性肿瘤(HM)易感基因,在1个家系3例血小板减少个体及14例无关BMF/HM个体中鉴定出ERG变异,表型包括血细胞减少和多种血液肿瘤且发病年龄小于40岁,功能研究显示致病性变异导致功能丧失(LOF),4例个体存在体细胞遗传拯救。
要点
- 生殖系ERG变异为常染色体显性遗传的BMF/HM易感因素,可表现为血小板减少、中性粒细胞减少、全血细胞减少及急性髓系白血病、骨髓增生异常综合征、急性淋巴细胞白血病。
- 13个潜在致病性ETS结构域错义变异显示功能丧失特征,破坏转录反式激活、DNA结合和/或核定位。
- 鉴定ERG易感变异对患者及家系诊断、遗传咨询、监测和治疗策略(包括骨髓供者选择及细胞或基因治疗)具有临床意义。
核心结论
- 生殖系ERG单倍剂量不足 defines a new syndrome with cytopenia and hematological malignancy predisposition,鉴定ERG易感变异对患者及家系诊断、咨询、监测和治疗策略(包括骨髓供者选择及细胞或基因治疗)具有临床意义。
研究设计与样本
- 研究报告在1个家系3例血小板减少个体中鉴定出罕见杂合ERG错义变异,并在无关BMF/HM个体中鉴定出14个额外ERG变异,包括2例新发变异和3个截短变异。
- 对20个ERG变异(19个错义和1个截短),包括3个错义人群变异,进行了功能鉴定。
主要发现
- 与致病性生殖系ERG变异相关的表型包括血细胞减少(血小板减少、中性粒细胞减少和全血细胞减少)和血液系统恶性肿瘤(急性髓系白血病、骨髓增生异常综合征和急性淋巴细胞白血病),发病年龄小于40岁。
- 13个潜在致病性ETS结构域错义变异显示功能丧失(LOF)特征,从而破坏转录反式激活、DNA结合和/或核定位。
- 选定的变异在小鼠胎肝细胞中过表达未能驱动髓系分化和培养中的不依赖细胞因子的生长,也未能促进移植到小鼠后的急性红白血病,与这些变异为LOF变异一致。
- 4例个体通过拷贝中性杂合性丢失显示体细胞遗传拯救。
临床怎么用
- 鉴定生殖系ERG易感变异对患者及家系诊断、遗传咨询、监测和治疗策略(包括骨髓供者选择及细胞或基因治疗)具有临床意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The genomics era has facilitated the discovery of new genes that predispose individuals to bone marrow failure (BMF) and hematological malignancy (HM). We report the discovery of ETS-related gene (ERG), a novel, autosomal dominant BMF/HM predisposition gene. ERG is a highly constrained transcription factor that is critical for definitive hematopoiesis, stem cell function, and platelet maintenance. ERG colocalizes with other transcription factors, including RUNX family transcription factor 1 (RUNX1) and GATA binding protein 2 (GATA2), on promoters or enhancers of genes that orchestrate hematopoiesis. We identified a rare heterozygous ERG missense variant in 3 individuals with thrombocytopenia from 1 family and 14 additional ERG variants in unrelated individuals with BMF/HM, including 2 de novo cases and 3 truncating variants. Phenotypes associated with pathogenic germ line ERG variants included cytopenias (thrombocytopenia, neutropenia, and pancytopenia) and HMs (acute myeloid leukemia, myelodysplastic syndrome, and acute lymphoblastic leukemia) with onset before 40 years. Twenty ERG variants (19 missense and 1 truncating), including 3 missense population variants, were functionally characterized. Thirteen potentially pathogenic erythroblast transformation specific (ETS) domain missense variants displayed loss-of-function (LOF) characteristics, thereby disrupting transcriptional transactivation, DNA binding, and/or nuclear localization. Selected variants overexpressed in mouse fetal liver cells failed to drive myeloid differentiation and cytokine-independent growth in culture and to promote acute erythroleukemia when transplanted into mice, concordant with these being LOF variants. Four individuals displayed somatic genetic rescue by copy neutral loss of heterozygosity. Identification of predisposing germ line ERG variants has clinical implications for patient and family diagnoses, counseling, surveillance, and treatment strategies, including selection of bone marrow donors and cell or gene therapy.
引用
- Zerella JR, Homan CC, Arts P, et al. Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition. Blood. 2024. PMID: 38991192. doi:10.1182/blood.2024024607
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。